Circadian mechanism may not be driver behind compound linked to obesity and diabetes

SR9009 is a compound that can lead to a wide range of health benefits in animals, including reduced risk of obesity and type 2 diabetes. Until now, researchers have attributed the effects to SR9009’s role in altering the body’s circadian clock. However, in a first-of-its-kind study from Penn Medicine, researchers found that SR9009 can effect cell growth and metabolic function without the involvement of REV-ERBs.
Source: EurekaAlert,